Correction to: First Development, Optimization, and Stability Control of a Pediatric Oral Atenolol Formulation

被引：0
|
作者：
Mauro Morri
Patricia Castellano
Darío Leonardi
Silvana Vignaduzzo
机构：
[1] Universidad Nacional de Rosario,Planta piloto de Producción de Medicamentos, Facultad de Ciencias Bioquímicas y Farmacéuticas
[2] Universidad Nacional de Rosario,Área Análisis de Medicamentos, Departamento Química Orgánica, Facultad de Ciencias Bioquímicas y Farmacéuticas
[3] IQUIR-CONICET,Área Técnica Farmacéutica, Departamento Farmacia, Facultad de Ciencias Bioquímicas y Farmacéuticas
[4] Universidad Nacional de Rosario,Facultad de Ciencias Bioquímicas y Farmacéuticas
[5] Universidad Nacional de Rosario,undefined
来源：
AAPS PharmSciTech | 2018年 / 19卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In the INTRODUCTION section, Atenolol is defined in parenthesis as (ATN, Fig. 1.) The correct definition is (ATN). Fig 1 corresponds to the RESULTS section.
引用
收藏
页码：3907 / 3907
相关论文
共 50 条
  • [31] QbD for pediatric oral lyophilisates development: risk assessment followed by screening and optimization
    Casian, Tibor
    Iurian, Sonia
    Bogdan, Catalina
    Rus, Lucia
    Moldovan, Mirela
    Tomuta, Ioan
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2017, 43 (12) : 1932 - 1944
  • [32] Amoxicillin chewable tablets intended for pediatric use: formulation development, stability evaluation and taste assessment
    Synaridou, Maria S.
    Monou, Paraskevi Kyriaki
    Zacharis, Constantinos K.
    Fatouros, Dimitrios G.
    Panderi, Irene
    Markopoulou, Catherine K.
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2021, 26 (09) : 978 - 988
  • [33] Development of automatic control system: simulation, optimization and analysis of stability
    Denisova, L. A.
    Meshcheryakov, V. A.
    Karabtsov, R. D.
    IV INTERNATIONAL SCIENTIFIC AND TECHNICAL CONFERENCE MECHANICAL SCIENCE AND TECHNOLOGY UPDATE (MSTU-2020), 2020, 1546
  • [34] Pullulan based oral thin film formulation of zolmitriptan: Development and optimization using factorial design
    Prajapati, Vipul D.
    Chaudhari, Anita M.
    Gandhi, Abhishek K.
    Maheriya, Pankaj
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2018, 107 : 2075 - 2085
  • [35] Formulation development of oral controlled release tablets of hydralazine: Optimization of drug release and bioadhesive characteristics
    Singh, Bhupinder
    Pahuja, Sonia
    Kapil, Rishi
    Ahuja, Naveen
    ACTA PHARMACEUTICA, 2009, 59 (01) : 1 - 13
  • [36] Etoposide Amorphous Nanopowder for Improved Oral Bioavailability: Formulation Development, Optimization, in vitro and in vivo Evaluation
    Wang, Yue
    Wang, Shuhang
    Xu, Yingju
    Wang, Ping
    Li, Sukai
    Liu, Lu
    Liu, Mengyan
    Jin, Xiangqun
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2020, 15 : 7601 - 7613
  • [37] Development of a Hydroxypropyl-β-Cyclodextrin-Based Liquid Formulation for the Oral Administration of Propranolol in Pediatric Therapy
    Cirri, Marzia
    Mura, Paola
    Benedetti, Simona
    Buratti, Susanna
    PHARMACEUTICS, 2023, 15 (09)
  • [38] Formulation Development and Optimization of Cefuroxime Axetil tablets by Direct Compression Method and its Stability Studies
    Muhammad, Iyad N.
    Shoaib, Muhammad H.
    Yousuf, RabRecia I.
    Hanif, Muhammad
    Jabeen, Sabahat
    LATIN AMERICAN JOURNAL OF PHARMACY, 2012, 31 (02): : 271 - 278
  • [39] Formulation development, stability and anticancer efficacy of core-shell cyclodextrin nanocapsules for oral chemotherapy with camptothecin
    Unal, Hale
    Ozturk, Naile
    Bilensoy, Erem
    BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY, 2015, 11 : 204 - 212
  • [40] Development of Extended-Release Oral Flexible Tablet (ER-OFT) Formulation for Pediatric and Geriatric Compliance: an Age-Appropriate Formulation
    Chandrasekaran, Prabagaran
    Kandasamy, Ruckmani
    AAPS PHARMSCITECH, 2017, 18 (07): : 2394 - 2409
12345